Home › Funds › Mizuho Markets Cayman LP › HALO
Mizuho Markets Cayman LP position in HALO
HALOZYME THERAPEUTICS INC · Health Care
Mizuho Markets Cayman LP reported holding 834,500 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$65.3M, representing 2.66% of its reported portfolio and ranking #7 among its reported holdings. Mizuho Markets Cayman LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Mizuho Markets Cayman LP's HALO position evolved
Mizuho Markets Cayman LP first disclosed a stake in HALO in Q2 2026 at 834,500 shares (US$65.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 834.50K | $65.32M | New |
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M sh · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M sh · $151.69M · Q2 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Stephens Investment Management Group LLC 1.39M sh · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M sh · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M sh · $84.77M · Q2 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
More on Mizuho Markets Cayman LP
FAQ
How long has Mizuho Markets Cayman LP held HALO?
Mizuho Markets Cayman LP has disclosed HALO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Mizuho Markets Cayman LP's current position in HALO?
As of Q2 2026, Mizuho Markets Cayman LP holds 834.50K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $65.32M, representing 2.66% of its reported portfolio and ranking #7.
Has Mizuho Markets Cayman LP been buying or selling HALO?
In the latest 13F filing (Q2 2026), Mizuho Markets Cayman LP newly opened its position in HALO.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.